超声与类风湿关节炎高危人群的系统性自身免疫或症状无关
该前瞻性队列研究纳入273例无明确风湿病的类风湿关节炎(RA)患者一级亲属,评估肌肉骨骼超声(MSUS)异常与RA不同临床前阶段的关联。结果显示活动性MSUS仅与未分类关节炎相关(OR 1.8,95%CI 1.0-3.3),与更早期RA发展阶段无关,不支持将超声 indiscriminately 用于临床前RA筛查。
要点
- 在RA一级亲属中,活动性MSUS与未分类关节炎相关,但与早期RA发展阶段无关。
- 活动性MSUS定义为总B模式评分>8且至少一个关节显著滑膜炎或滑膜血供增多。
- 不建议将超声 indiscriminately 用于临床前RA的筛查策略。
核心结论
- 在RA高危个体中,活动性MSUS仅与未分类关节炎相关,与已描述的其他早期RA发展阶段无关。
研究设计与样本
- 前瞻性队列研究,纳入273例无明确风湿病的RA患者一级亲属(RA-FDRs)。
- 采用验证过的SONAR评分评估MSUS炎症活动,活动性MSUS定义为总B模式评分>8且至少一个关节显著滑膜炎(2或3级)或显著滑膜血供增多(多普勒评分>1)。
- 使用 logistic 回归分析MSUS表现与公认的RA临床前阶段的关联,并调整其他人口学和生物学特征。
主要发现
- 273例RA-FDRs中,23例(8%)抗瓜氨酸化蛋白自身抗体阳性,58例(21%)有未分类关节炎,96例(35%)有活动性MSUS。
- 活动性MSUS仅与未分类关节炎相关(OR 1.8,95%CI 1.0-3.3)。
关键数值与推荐
- 活动性MSUS定义:总B模式评分>8,包括至少一个关节显著滑膜炎(2或3级)或显著滑膜血供增多(多普勒评分>1)。
临床怎么用
- 在RA高危个体中,超声发现活动性MSUS应结合未分类关节炎进行评估,但不建议将其作为临床前RA的普遍筛查工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify whether musculoskeletal ultrasound (MSUS) abnormalities are associated with specific phases of rheumatoid arthritis (RA) development in individuals at risk of RA. METHODS: This is a prospective cohort study of individuals at risk of developing RA, namely first-degree relatives of patients with RA (RA-FDRs) without evidence of established rheumatic disease at inclusion. The inflammatory activity on MSUS was assessed according to a validated score (SONAR). Active MSUS was defined as a total B-mode score greater than 8, including at least one joint with significant synovitis (grade 2 or 3) or significant synovial hyperaemia (Doppler score greater than 1). We used logistic regression to analyse associations between MSUS findings and recognised preclinical phases of RA development, adjusting for other demographic and biological characteristics. RESULTS: A total of 273 RA-FDRs were analysed, of whom 23 (8%) were anticitrullinated protein autoantibodies-positive, 58 (21%) had unclassified arthritis and 96 (35%) had an active MSUS, which was only associated with unclassified arthritis (OR: 1.8, 95% CI 1.0 to 3.3). CONCLUSION: In individuals at risk of RA, active MSUS was associated with the presence of unclassified arthritis, but not with any of the earlier described phases of RA development. These findings do not support an indiscriminate use of ultrasound in a screening strategy for preclinical RA.
引用
- Brulhart L, Alpízar-Rodríguez D, Nissen MS, et al. Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis. RMD Open. 2019. PMID: 31565240. doi:10.1136/rmdopen-2019-000922
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。